Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.17 (
CaMKII
)
4,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
NHE3
, a cloned intestinal and renal brush border Na+/H+ exchanger, has previously been shown to be both stimulated and inhibited by different protein kinases/growth factors. For instance,
NHE3
is stimulated by serum and fibroblast growth factor (FGF) and inhibited by protein kinase C. In the present study, we used a series of
NHE3
C terminus truncation mutants to identify separate regions of the C-terminal cytoplasmic tail responsible for stimulation and inhibition by protein kinases/growth factors. Five
NHE3
C terminus truncation mutant stable cell lines were generated by stably transfecting
NHE3
deletion cDNAs into PS120 fibroblasts, which lack any endogenous Na+/H+ exchanger. Using fluorometric techniques, the effects of the calcium/calmodulin (CaM) inhibitor W13, calcium/
CaM kinase
inhibitor KN-62, phorbol myristate acetate, okadaic acid, FGF, and fetal bovine serum on Na+/H+ exchange were studied in these transfected cells. Inhibition of basal activity of full-length
NHE3
is mediated by CaM at a site C-terminal to amino acid 756; this CaM effect occurs through both kinase dependent and independent mechanisms. There is another independent inhibitory domain for protein kinase C between amino acids 585 and 689. In addition, there are at least three stimulatory regions in the C-terminal domain of
NHE3
, corresponding to amino acids 509-543 for okadaic acid, 475-509 for FGF, and a region N-terminal to amino acid 475 for fetal bovine serum. We conclude that separate regions of the C terminus of
NHE3
are involved with stimulation or inhibition of Na+/H+ exchange activity, with both stimulatory and inhibitory domains having several discrete subdomains. A conservative model to explain the way these multiple domains in the C terminus of
NHE3
regulate Na+/H+ exchange is via an effect on associated regulatory proteins.
...
PMID:Separate C-terminal domains of the epithelial specific brush border Na+/H+ exchanger isoform NHE3 are involved in stimulation and inhibition by protein kinases/growth factors. 777 26
Angiotensin II (ANG II) stimulates renal tubular reabsorption of NaCl by targeting Na(+)/H(+) exchanger
NHE3
. We have shown previously that inositol 1,4,5-triphosphate receptor-binding protein released with inositol 1,4,5-triphosphate (IRBIT) plays a critical role in stimulation of
NHE3
in response to elevated intracellular Ca(2+) concentration ([Ca(2+)](i)). In this study, we investigated the role of IRBIT in mediating
NHE3
activation by ANG II. IRBIT is abundantly expressed in the proximal tubules where
NHE3
is located. ANG II at physiological concentrations stimulates
NHE3
transport activity in a model proximal tubule cell line. ANG II-induced activation of
NHE3
was abrogated by knockdown of IRBIT, whereas overexpression of IRBIT enhanced the effect of ANG II on
NHE3
. ANG II transiently increased binding of IRBIT to
NHE3
at 5 min but became dissociated by 45 min. In comparison, it took at least 15 min of ANG II treatment for an increase in
NHE3
activity and
NHE3
surface expression. The stimulation of
NHE3
by ANG II was dependent on changes in [Ca(2+)](i) and Ca(2+)/calmodulin-dependent protein kinases II. Inhibition of
CaMKII
completely blocked the ANG II-induced binding of IRBIT to
NHE3
and the increase in
NHE3
surface abundance. Several serine residues of IRBIT are thought to be important for IRBIT binding. Mutations of Ser-68, Ser-71, and Ser-74 of IRBIT decreased binding of IRBIT to
NHE3
and its effect on
NHE3
activity. In conclusion, our current findings demonstrate that IRBIT is critically involved in mediating activation of
NHE3
by ANG II via a Ca(2+)/calmodulin-dependent protein kinases II-dependent pathway.
...
PMID:Activation of Na+/H+ exchanger NHE3 by angiotensin II is mediated by inositol 1,4,5-triphosphate (IP3) receptor-binding protein released with IP3 (IRBIT) and Ca2+/calmodulin-dependent protein kinase II. 2058 8